Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$54M
1 round on record
Latest round
$54M
Venture round · Jul 2024 · 2 yr ago
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 8, 2024 Raised a round Venture round $54M · News Powered by Cision 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2024 $54M — News Powered by Cision
Registers and programsofficial lists and records that name the company
Legal entity SmartCella Holding AB its site
Founders and leadersfrom filings, registers and the company's site
Scientific AdvisoryDirectorscompany's site
Similar startupsby what they do, their industry and backers
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
CurileumVenture round · 5 mo ago · 51-200 employees
Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…
Vira RegenFounded 2023 · 11-50 employees
Vira Regen develops noninvasive, gene-targeted electrostimulation devices for bone regeneration. OsteoVolt is in preclinical development…
About Us Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene…
Waypoint Bio11-50 employees
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
Verismo TherapeuticsVenture round $28M · 6 mo ago · 201-500 employees
A paradigm-shifting technology featuring KIR-based CAR construct that has been proven to reduce T cell exhaustion & kill solid tumor models…

Overview

The future of targeted therapies. The Extroducer® is a novel, modality-agnostic endovascular infusion catheter with the ability to delivery payload directly to targeted cardiac and pancreatic tissues and solid tumors.

News

News YahooFinance 1 year ago
SmartCella gains rights to advance cell therapy research for Parkinson's
The company signed the agreement with Karolinska Institutet
Read more
Report
News FinanzNachrichten.de 2 years ago
Aqua Metals Raises $13 Million from Leading Institutional Investor to Accelerate Commercialization and Strategic Growth
RENO, Nev., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium battery recycling with its proprietary AquaRefining technology, today announced it has
Read more
Report
News News Powered by Cision 2 years ago
SmartCella raises EUR 50 million to accelerate growth and commercialization
SmartCella Holding AB (
Read more
Report
News FinanzNachrichten.de 2 years ago
Catalent, Inc.: SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
SmartCella Holding AB ("SmartCella"), a global biopharma company developing and manufacturing cutting-edge cell therapy approaches for difficult-to-treat diseases, and Catalent, Inc., the leader in enabling
Read more
Report
News News Powered by Cision 2 years ago
SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies
SmartCella, through its business unit ProCella, has been approved by the Swedish Medicinal Product
Read more
Report

Tech stack

The technologies known for SmartCella, by layer.
Developer tools
Mandiant capa
Sign in to see how your skills match this stack Sign In

People

Scientific Advisory
Directors
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Tumba
Tumba Sweden
HQ
1 open roles 1 posted in 90 days 100% engineering
hires for Hardware
Alfred Nobels allé 150
seen since Oct 2026 job postings

Financials

Total raised
$54M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $54M Details